Effect of an Intervention Program of Adapted Physical Activity Combined With Compensatory Nutrition in Patients With Constitutional Thinness (ANIMATION)
Constitutional Thinness (CT) is a form of stable thinness without malnutrition but with resistance to weight gain, affecting approximately 1% of the general population. The clinical consequences are numerous and the pathophysiology remains poorly understood.
Currently, conventional management involves a high-calorie and frequent diet, combined with the avoidance of endurance physical activity, although there is no significant evidence of its effectiveness.
Our hypothesis is that an adapted physical activity program (APA) combined with compensatory nutrition (CN) could help these patients gain lean mass (muscle mass).
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Natacha GERMAIN, PhD
- Phone Number: +33 (0)477120621
- Email: natacha.germain@chu-st-etienne.fr
Study Contact Backup
- Name: Florence RANCON, Cheffe de projet
- Phone Number: +33 (0) 477829458
- Email: florence.rancon@chu-st-etienne.fr
Study Locations
-
-
France
-
Saint-Etienne, France, France, 42055
- Recruiting
- CHU de Saint-Etienne
-
Contact:
- Natacha GERMAIN, PhD
- Phone Number: +33 (0)477120621
- Email: natacha.germain@chu-st-etienne.fr
-
Contact:
- Florence RANCON, Cheffe de projet
- Phone Number: +33 (0) 477829458
- Email: florence.rancon@chu-st-etienne.fr
-
Sub-Investigator:
- Bogdan GALUSCA, PhD
-
Sub-Investigator:
- David HUPIN, PhD
-
Sub-Investigator:
- Leonard FEASSON, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gender: Female
- BMI: ≤ 18.5 kg/m²
- Weight Stability: Stable weight for at least 3 months
- Age: 18 to 50 years old at the inclusion visit
- Diagnosed with Constitutional thinness
Exclusion Criteria:
- Pregnancy, Parturition, or Lactation
- Legal Restrictions: Individuals deprived of liberty, involuntarily hospitalized, or hospitalized for reasons other than research purposes, adults under legal protection (guardianship or curatorship) or unable to provide consent
- Eating Disorders: Individuals with eating disorders (DSM IV and 5 criteria)
- Excessive Alcohol Consumption: Consumption exceeding the equivalent of 10 glasses of wine per week
- Severe Progressive Conditions: Progressive severe conditions (e.g., diabetes)
- Intense Physical Activity: Individuals engaging in intense physical activity (> 3 sessions per week)
- Heavy Smoking: Significant smoking (>10 cigarettes per day)
- Psychiatric Conditions: Presence of depressive or psychiatric conditions requiring antidepressant or psychotropic treatment
- Medical or Surgical History: Medical or surgical history deemed incompatible with the study by the investigator
- MRI Contraindication: Individuals with contraindications to MRI will not undergo spectro-MRI analyses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: APA + NC
|
The APA intervention will consist of a 2-week running-in period, followed by a period of adapted physical activity (APA) for 8 weeks. The Compensatory Nutrition (NC) intervention will consist of a 2-week running-in period, followed by a period of compensated nutrition (NC) for 8 weeks. |
|
No Intervention: Control
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lean body mass
Time Frame: From day 1 to week 8
|
Lean body mass gain (kg) measured by bioimpedance |
From day 1 to week 8
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI
Time Frame: From day 1 to week 8
|
Body masse index : ratio between weight and height |
From day 1 to week 8
|
|
Energy balance
Time Frame: From day 1 to week 8
|
Ratio between calorie intake and calorie expenditure Caloric intake measured by dietary records over 2 weeks (calorie); Calorie expenditure: Resting metabolism measured by indirect calorimetry (kcal/24h); + Postprandial thermogenesis measured by indirect calorimetry (kcal/24h);; + Physical activity energy expenditure measured by connected watch (kcal/24h); |
From day 1 to week 8
|
|
Physical exercise capacity
Time Frame: From day 1 to week 8
|
Changes in VO2max |
From day 1 to week 8
|
|
Quality of life SF-12 questionnaire
Time Frame: From day 1 to week 8
|
SF-12 questionnaire; Self-measurement questionnaire SF-12 (Short Form Health Survey 12); comprising 12 questions assessing 8 dimensions, namely physical functioning, role limitation due to physical problems, role limitation resulting from emotional problems, vitality (energy/fatigue), emotional well-being, social functioning, bodily pain, and perception of general and mental health; each dimension is represented by a score ranging from 0 to 100, with a low score signifying poor health perception in the dimension considered, and a high score signifying the opposite); |
From day 1 to week 8
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 24CH263
- ANSM (Other Identifier: 2025-A00088-41)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.